Fusion Analysis in CBTN RNAseq Data
Email Principal Investigator
About this
Project
Gene fusions occur when two formally independent genes merge to create a new gene. These gene fusions also result in fusion proteins, proteins that may otherwise not be made by the cell. Gene fusions and their fusion proteins have been shown to play a role in the development of cancers, including pediatric brain cancers. Researchers will analyse the pediatric brain tumor RNAseq data for fusions, which may be possible therapy targets. A small cohort of the same tumors at Weill Cornell will be compared to data from the Pediatric Brain Tumor Atlas. By comparing data analysis from two sources, researchers can further verify their findings and possibly accelerate the development of therapies for pediatric brain cancers. The Children's Brain Tumor Network contributed to this project by providing access to the Pediatric Brain Tumor Atlas.
Ask The
Scientists
What are the goals of this project?
Researchers will complete a comparative analysis of cancer data in an effort to find targets for new therapeutics.
What is the impact of this project?
Comparative analysis will allow researchers to verify their findings, thus accelerating the development of therapies for pediatric brain cancers.
Why is the CBTN request important to this project?
This project requires high quality data for analysis and comparison, making access to the Pediatric Brain Tumor Atlas particularly important for researchers.
Specimen Data
The Chldren's Brain Tumor Network contributed to this project by providing access to the Pediatric Brain Tumor Atlas
Meet The
Team

Andrea Sboner, PhD
Computational analysis of the human transcriptome and proteome

Weill Cornell Medicine

Scientific Committee
Olivier Elemento, PhD
Big Data analytics with experimentation to develop entirely new ways to help prevent, diagnose, understand, treat and ultimately cure cancerSystems biology of regulatory networks in normal and malignant cellsCancer genomics and precision medicineEpigenomics of cancerTumor genome evolution, anticance

Weill Cornell Medicine

Scientific Committee
David Pisapia, MD
Dr. Pisapia's research interests include furthering the molecular characterization of brain tumors in an effort to reveal therapeutically and prognostically meaningful subclassifications of heterogeneous brain tumors that are often lumped into a single diagnostic entity.

Weill Cornell Medicine
Juan Miguel Mosquera, MD, MSc

Weill Cornell Medicine
Rohan Bareja

Weill Cornell Medicine
related